Glossary entry (derived from question below)
English term or phrase:
marque surtout les restes folliculaires
French translation:
labels preferentially remaining FL cells
Added to glossary by
Drmanu49
Nov 19, 2017 13:55
6 yrs ago
2 viewers *
English term
New Caledonia
Professional, reliable and confidential
Native in: French (Variant: Standard-France) 
, English (Variants: British, US)
Works in: English to French, French to English, English, and 1 more.
marque surtout les restes folliculaires
English to French
Medical
Medical (general)
cancer
Le Ki67 marque surtout les restes folliculaires.
Biopsy results.
Thanks for your help.
Biopsy results.
Thanks for your help.
Proposed translations
(French)
| 3 | labels preferentially remaining FL cells |
Drmanu49
|
| 4 | especially/in particular shows/highlights the rest of the follicles |
liz askew
|
Change log
Nov 25, 2017 12:50: Drmanu49 changed "Edited KOG entry" from "<a href="/profile/97451">Ghyslaine LE NAGARD's</a> old entry - "marque surtout les restes folliculaires"" to ""labels preferentially remaining FL cells""
Proposed translations
16 mins
Selected
labels preferentially remaining FL cells
The diagnostic and prognostic values of Ki-67/MIB-1 expression in ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505609/ - Traduire cette page
de D Pan - 2017
3 juil. 2017 - Also, the meta-analysis indicated that Ki-67/MIB-1 might have an ... cancer (PTC), follicular thyroid cancer, medullary thyroid cancer, ... So, the significance of Ki-67/MIB-1 for prognostication of thyroid cancer remains uncertain.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505609/ - Traduire cette page
de D Pan - 2017
3 juil. 2017 - Also, the meta-analysis indicated that Ki-67/MIB-1 might have an ... cancer (PTC), follicular thyroid cancer, medullary thyroid cancer, ... So, the significance of Ki-67/MIB-1 for prognostication of thyroid cancer remains uncertain.
4 KudoZ points awarded for this answer.
Comment: "Thanks"
4 hrs
especially/in particular shows/highlights the rest of the follicles
https://www.spandidos-publications.com/mmr/11/3/1566
by LT Li - 2015 - Cited by 44 - Related articles
10 Nov 2014 - As a proliferation marker to measure the growth fraction of cells in human tumors, the expression of Ki67 is strongly associated with cell proliferation and is widely used in routine pathology. pKi67 is well characterized at the molecular level and extensively used as a prognostic and predictivemarker in cancer.
http://e-immunohistochemistry.info/web/Ki-67.htm
Follicles show a high level of staining, with a polarity; there is almost 100% staining of nuclei in the dark zone, which tends to form a meniscus. The borders of the follicles are sharply demarcated from the mantle which has a low proliferation rate. Some follicles may lack the typical pattern, so multiple follicles should be assessed: this is the case if the section is purely through the light zone.
Reactive Lymphadenopathy - The Student Source
https://www.med-ed.virginia.edu/courses/path/innes/wcd/react...
1.
2.
The lymph node response to stimuli varies. Follicles can increase in size and number; sinuses can enlarge and fill with histiocytes, or the architecture can be ...
https://books.google.co.uk/books?id=q6osDwAAQBAJ&pg=PA8&lpg=...
--------------------------------------------------
Note added at 4 hrs (2017-11-19 18:52:13 GMT)
--------------------------------------------------
OR
........the remaining follicles
https://books.google.co.uk/books?isbn=0323511872
Kirby I. Bland, Edward M. Copeland, V. Suzanne Klimberg - 2017 - Medical
Cancer. LINDSAY F. PETERSEN,a MOLLY MORAVEK,a TERESA K. ... In the cancer setting, the number of follicles remaining is important for knowing whether ...
--------------------------------------------------
Note added at 4 hrs (2017-11-19 18:54:00 GMT)
--------------------------------------------------
https://books.google.co.uk/books?isbn=3319262912
Sandra J. Shin - 2016 - Medical
Neoplastic lymphocytes express CD20 (a). Immunohistochemical stain for Ki67 highlights virtually every tumor cell with a proliferation rate close to 100% (b) Fig.
by LT Li - 2015 - Cited by 44 - Related articles
10 Nov 2014 - As a proliferation marker to measure the growth fraction of cells in human tumors, the expression of Ki67 is strongly associated with cell proliferation and is widely used in routine pathology. pKi67 is well characterized at the molecular level and extensively used as a prognostic and predictivemarker in cancer.
http://e-immunohistochemistry.info/web/Ki-67.htm
Follicles show a high level of staining, with a polarity; there is almost 100% staining of nuclei in the dark zone, which tends to form a meniscus. The borders of the follicles are sharply demarcated from the mantle which has a low proliferation rate. Some follicles may lack the typical pattern, so multiple follicles should be assessed: this is the case if the section is purely through the light zone.
Reactive Lymphadenopathy - The Student Source
https://www.med-ed.virginia.edu/courses/path/innes/wcd/react...
1.
2.
The lymph node response to stimuli varies. Follicles can increase in size and number; sinuses can enlarge and fill with histiocytes, or the architecture can be ...
https://books.google.co.uk/books?id=q6osDwAAQBAJ&pg=PA8&lpg=...
--------------------------------------------------
Note added at 4 hrs (2017-11-19 18:52:13 GMT)
--------------------------------------------------
OR
........the remaining follicles
https://books.google.co.uk/books?isbn=0323511872
Kirby I. Bland, Edward M. Copeland, V. Suzanne Klimberg - 2017 - Medical
Cancer. LINDSAY F. PETERSEN,a MOLLY MORAVEK,a TERESA K. ... In the cancer setting, the number of follicles remaining is important for knowing whether ...
--------------------------------------------------
Note added at 4 hrs (2017-11-19 18:54:00 GMT)
--------------------------------------------------
https://books.google.co.uk/books?isbn=3319262912
Sandra J. Shin - 2016 - Medical
Neoplastic lymphocytes express CD20 (a). Immunohistochemical stain for Ki67 highlights virtually every tumor cell with a proliferation rate close to 100% (b) Fig.
Discussion
1. What is the patient's medical history?
2. Is the patient male or female?
3. Where has the biopsy been taken, i.e. which part of the body?